Pureos Bioventures
CEO and President of Neurimmune; key opinion leader in neurodegenerative diseases; developer of aducanumab (Alzheimer’s disease) now in partnership with Biogen. Part-time professor at the Institute for Regenerative Medicine, University of Zurich.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Pureos Bioventures
Pureos is a venture capital fund investing in private innovative drug development companies.